<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00753181</url>
  </required_header>
  <id_info>
    <org_study_id>BK21</org_study_id>
    <nct_id>NCT00753181</nct_id>
  </id_info>
  <brief_title>Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes</brief_title>
  <official_title>Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate average daily blood glucose in subjects with type 2 diabetes following a Meal
      Plan including Diabetes-Specific products compared to average daily blood glucose in subjects
      following their usual diet.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average daily blood glucose level</measure>
    <time_frame>11 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of time in specified glucose ranges; Glycemic excursions; Change in plasma glucose, insulin, free fatty acids, triglycerides, 1,5-anhydroglucitol, and fructosamine; Dietary intake variables</measure>
    <time_frame>11 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>A1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diabetes Meal Plan with Experimental Diabetes-Specific nutritional shake</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diabetes Meal Plan with Experimental Diabetes-Specific Nutritional Shake, diabetes specific Cereal, and diabetes specific snack bars.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Formula</intervention_name>
    <description>nutritional shake daily</description>
    <arm_group_label>A1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual diet</intervention_name>
    <description>usual dietary habits</description>
    <arm_group_label>A2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diabetes Meal Plan with experimental diabetes-specific nutritional shake, diabetes specific cereal, and diabetes specific snack bars.</intervention_name>
    <description>nutritional shake, diabetes specific cereal and diabetes snack bar daily</description>
    <arm_group_label>A3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. type 2 diabetes

          2. HbA1c &gt;6.5% and &lt;11.0%

          3. male/non-pregnant, non-lactating female, at least 6 months postpartum

          4. if female of childbearing potential, practicing method of birth control

          5. Body Mass Index &gt; 18.5 kg/m2 and &lt; 43.0 kg/m2.

          6. weight stable for past two months

          7. if on anti-hypertensive, lipid-lowering, thyroid medication or hormone therapy, dosage
             constant for at least two months

        Exclusion Criteria:

          1. uses injected medications (e.g., insulin, exenatide) for glucose control.

          2. history of diabetic ketoacidosis

          3. current infection ; inpatient surgery, or corticosteroid treatment in the last 3
             months or antibiotics in the last 3 weeks

          4. active malignancy

          5. states he/she has had a significant cardiovascular event &lt; 12 weeks prior to study
             entry or history of congestive heart failure in the last 12 months.

          6. end stage organ failure

          7. active metabolic, hepatic, or gastrointestinal disease that may interfere with
             nutrient absorption, distribution, metabolism, or excretion (such as gastroparesis),
             excluding diabetes.

          8. chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or
             C, or HIV.

          9. use of herbals, dietary supplements, or medications, other than allowed medications,
             during past four weeks that could profoundly affect blood glucose.

         10. symptomatic in response to blood collection prior to enrollment into this study.

         11. clotting or bleeding disorders.

         12. non-typical eating pattern

         13. is currently using diabetes-specific nutritional product(s)defined as more than one
             eating occasion per week.

         14. engages in strenuous exercise five or more times per week.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vikkie Mustad, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Provident Clinical Research</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2008</study_first_submitted>
  <study_first_submitted_qc>September 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2008</study_first_posted>
  <last_update_submitted>April 24, 2009</last_update_submitted>
  <last_update_submitted_qc>April 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2009</last_update_posted>
  <responsible_party>
    <name_title>Bobbie Swearengin, Director Clinical Research Operations</name_title>
    <organization>Abbott Nutrition</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

